• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current status of multiple markers in precision immunotherapy for colorectal cancer.

作者信息

Liu Chao, Lan Ya, Wang Hong, Zhang Yanqiao

机构信息

Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China.

Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150000, China.

出版信息

Cancer Biol Med. 2025 Mar 26;22(3):205-11. doi: 10.20892/j.issn.2095-3941.2025.0030.

DOI:10.20892/j.issn.2095-3941.2025.0030
PMID:40135880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11976704/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/11976704/2d9ae65f8980/cbm-22-205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/11976704/2d9ae65f8980/cbm-22-205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/11976704/2d9ae65f8980/cbm-22-205-g001.jpg

相似文献

1
Current status of multiple markers in precision immunotherapy for colorectal cancer.结直肠癌精准免疫治疗中多种标志物的现状
Cancer Biol Med. 2025 Mar 26;22(3):205-11. doi: 10.20892/j.issn.2095-3941.2025.0030.
2
Immunotherapy in colorectal cancer: What have we learned so far?结直肠癌的免疫治疗：我们目前学到了什么？
Clin Chim Acta. 2016 Sep 1;460:78-87. doi: 10.1016/j.cca.2016.06.027. Epub 2016 Jun 24.
3
Current status and prospect of immunotherapy for colorectal cancer.结直肠癌免疫治疗的现状与展望。
Int J Colorectal Dis. 2023 Nov 14;38(1):266. doi: 10.1007/s00384-023-04553-z.
4
Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer.预测结直肠癌免疫检查点抑制剂治疗的分子标志物。
J Clin Lab Anal. 2022 Jan;36(1):e24141. doi: 10.1002/jcla.24141. Epub 2021 Nov 24.
5
[Current status, controversy and challenge in the neoadjuvant immunotherapy of colorectal cancer].[结直肠癌新辅助免疫治疗的现状、争议与挑战]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Mar 25;25(3):185-192. doi: 10.3760/cma.j.cn441530-20211219-00510.
6
Current status of immunotherapy in metastatic colorectal cancer.转移性结直肠癌免疫治疗的现状
Int J Colorectal Dis. 2019 Jan;34(1):13-25. doi: 10.1007/s00384-018-3202-8. Epub 2018 Nov 21.
7
Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives.迈向结直肠癌患者精准免疫检查点阻断免疫治疗：策略与展望。
Biomed Pharmacother. 2022 May;149:112923. doi: 10.1016/j.biopha.2022.112923. Epub 2022 Apr 6.
8
The current status and prospect of immunotherapy in colorectal cancer.结直肠癌免疫治疗的现状与展望。
Clin Transl Oncol. 2024 Jan;26(1):39-51. doi: 10.1007/s12094-023-03235-0. Epub 2023 Jun 10.
9
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.结直肠癌的免疫和基质分类与分子亚型相关，并与精准免疫治疗相关。
Clin Cancer Res. 2016 Aug 15;22(16):4057-66. doi: 10.1158/1078-0432.CCR-15-2879. Epub 2016 Mar 18.
10
Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies.结直肠癌精准医学方法的进展：从分子剖析到靶向治疗。
ACS Pharmacol Transl Sci. 2024 Mar 19;7(4):967-990. doi: 10.1021/acsptsci.4c00008. eCollection 2024 Apr 12.

本文引用的文献

1
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy.从混乱到有序：优化粪便微生物群移植以提高免疫检查点抑制剂疗效
Gut Microbes. 2025 Dec;17(1):2452277. doi: 10.1080/19490976.2025.2452277. Epub 2025 Jan 18.
2
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.利用肿瘤微环境：通过调节上皮-间质转化实现靶向癌症治疗
J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6.
3
Multiomics Reveals the Immunologic Features and the Immune Checkpoint Blockade Potential of Colorectal Medullary Carcinoma.
多组学揭示结直肠髓样癌的免疫特征及免疫检查点阻断潜力
Clin Cancer Res. 2025 Feb 17;31(4):773-786. doi: 10.1158/1078-0432.CCR-24-2505.
4
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.在CO.26试验中，血浆与组织肿瘤突变负荷作为转移性结直肠癌患者接受度伐利尤单抗加曲美木单抗治疗反应的生物标志物
Clin Cancer Res. 2024 Aug 1;30(15):3189-3199. doi: 10.1158/1078-0432.CCR-24-0268.
5
Antitumor Immune Responses in B2M-Deficient Cancers.B2M 缺陷型癌症中的抗肿瘤免疫反应。
Cancer Immunol Res. 2023 Dec 1;11(12):1642-1655. doi: 10.1158/2326-6066.CIR-23-0139.
6
At the Crossroads of TNF α Signaling and Cancer.在 TNFα 信号与癌症的十字路口。
Curr Mol Pharmacol. 2024;17(1):e060923220758. doi: 10.2174/1874467217666230908111754.
7
Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.KMT2C/D 功能丧失变异与结直肠癌免疫检查点阻断治疗反应的相关性。
Cancer Sci. 2023 Apr;114(4):1229-1239. doi: 10.1111/cas.15716. Epub 2023 Jan 24.
8
Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression.多重免疫荧光成像揭示了黏液型直肠癌富含免疫的肿瘤微环境，其特征为淋巴细胞浸润增加和程序性细胞死亡蛋白 1 表达增强。
Dis Colon Rectum. 2023 Jul 1;66(7):914-922. doi: 10.1097/DCR.0000000000002624. Epub 2022 Nov 17.
9
Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon.结直肠锯齿状腺癌的临床、病理遗传学及肿瘤内免疫微环境。
Histopathology. 2022 Sep;81(3):380-388. doi: 10.1111/his.14719. Epub 2022 Jul 20.
10
Colorectal adenosquamous carcinoma: Peculiar morphologic features and distinct immunoprofiles in squamous and glandular components.结直肠腺鳞癌：鳞状和腺体成分具有独特的形态学特征和不同的免疫表型。
Pathol Res Pract. 2022 Aug;236:153967. doi: 10.1016/j.prp.2022.153967. Epub 2022 May 30.